SUMMARY Background: Major depressive disorder (MDD) is one of the most common disorders in the world
INTRODUCTION
Major depressive disorder (MDD) is one of the most common disorders in the world, and its symptoms impair mood and cognition, physical health, and social and occupational functioning. MDD is generally refractory to antidepressant treatment, and can cycle between symptomatic activation and remission; notably, remitted patients do not show any MDD symptoms. However, recent developments in neurocognitive measurement have demonstrated that cognitive dysfunction is still present in patients with MDD despite their being symptomatically remitted (Rock et al. 2014 ).
The lack of antidepressant response in patients with MDD has forced the development of other treatment strategies, one of which is physical exercise. Exercise has shown some benefit in patients with MDD. For example, a systematic review and meta-analysis by Schuch et al. (2016) showed that physical exercise decreased depressive symptoms in patients with MDD, while Stubbs et al. (2016) also demonstrated improved cardiorespiratory fitness in patients with MDD. Thus, physical exercise intervention improved not only MDD symptoms but also physical health. The relative safety and lack of side effects of physical exercise as a treatment for depression are well-known (Lam et al. 2016) , and its efficacy rivals that of psychopharmacological treatment (Cooney et al. 2013 ). These traits make physical exercise a strong candidate treatment option for MDD.
However, the mechanism underlying the effects of physical exercise on depressive symptoms remains unclear. An increase in brain-derived neurotrophic factor (BDNF) is one putative mechanism. BDNF concentrations in patients with depression were significantly lower than those in healthy controls (Sen et al. 2008) , and were negatively correlated with depressive symptoms (Caldieraro et al. 2017) . A meta-analysis by Zhou et al. (2017) determined that antidepressant drugs increase BDNF concentrations as well as decrease depressive symptoms. However, it is unclear whether physical exercise increases BDNF in patients with MDD. The aim of this meta-analysis was to clarify whether physical exercise increases BDNF in patients with MDD, and thus determine if such a mechanism could be at work in the benefits of physical exercise on depressive symptoms in patients with MDD.
SUBJECTS AND METHODS

Subjects
This meta-analysis included only previously published literature; therefore, its subjects were ethically protected.
Methods
Search strategy
Five electronic databases (PubMed, PsycINFO, CHINAL, Cochrane Library, and Japanese Central Review of Medicine) were searched for records dated up to 24 October 2017, using the following 3 keyword groups (with wildcards):
Major depressive disorder; (Tai-chi or exergame or yoga or lift* or resistance or "physical medicine" or train* or fitness or activity* or strength* or bicycle* or cycling or aquatic* or swim* or hiking or walk* or jogging or running or aerobic* or exercise*); ("Brain-derived neurotrophic factor" or BDNF).
Each group was searched separately; then, the collected results from all 3 search groups were searched by joining all three keyword groups into one search formula with Boolean AND operators.
Inclusion criteria
The inclusion criteria for this review were: all participants (intervention and control groups) were patients with MDD; BDNF quantified in plasma or serum; conducted physical activity or exercise as the intervention; a randomized controlled study design; not a review article. The overall search strategy is summarized in Figure 1 .
Analysis
Two types of analyses of eligible articles were utilized, a narrative analysis and a meta-analysis.
Narrative analysis
Eligible articles were narratively analyzed for aspects including: (1) features of subjects; (2) type of physical exercise used for intervention; (3) duration of intervention; (4) drop-out rates.
Meta-analysis
The change in plasma/serum BDNF from the preintervention baseline levels to those after the intervention were calculated for all participants with a standard mean difference and random effect model. All meta-analyses were performed using Review Manager 5 (The Nordic Cochrane Center, The Cochrane Collaboration 2011, Copenhagen, Denmark). All eligible articles were assessed for the risk of bias using the Cochrane Handbook for Systematic Reviews of Interventions (Higgins et al. 2011), which assesses 6 aspects of potential risk: Random sequence generation, allocation concealment, blinding of outcome assessment, blinding of participants and personnel, incomplete outcome data, and selective reporting. 
RESULTS
As shown in Figure 1 , of the 564 articles identified by the search terms, 5 articles (n=199 participants) met the inclusion criteria. The key features of the eligible articles are summarized in Table 1 .
Narrative analysis
Features of subjects
The severity of the depressive symptoms in the subjects at baseline in all eligible articles was assessed by either the Beck Depression Inventory or a variant of the Hamilton Depression Rating Scale. Average severity scores were categorized as severe or worse according to the categorical definitions for each scale (Sajatovic et al. 2012) . Of the 5 eligible articles, 4 articles applied inclusion or exclusion criteria based on symptom severity, and 2 articles included only patients with symptom severity categorized as worse than "moderate" (Schuch et al. 2014 , Salehi et al. 2016 . One article applied inclusion or exclusion criteria based on suicidal behavior (Krogh et al. 2014 ). The average ages in all eligible articles were around 40 years, except for one article in which the average age was 68 years. Four studies recruited inpatients, whereas one recruited outpatients.
Type of physical exercise as intervention
All eligible articles introduced aerobic exercise in some form. Most studies used bicycles, but treadmills, rowing, and other forms of aerobic training were introduced; in two articles, the participants could choose the exercise modality from a list of 3-5 choices according to their preference.
Duration of intervention
Four of the five studies conducted interventions lasting less than 40 minutes per session, and one article did not describe the session length. In terms of frequency, three studies conducted sessions 3 times per week, and the other two studies conducted two sessions per week. Four studies conducted sessions for over 3 weeks.
Drop-out rates
In all eligible articles, drop-out rate was reported to be less than 20%. Notably, the two studies which allowed participants to choose their exercise had no drop-outs (0%).
Meta-analysis
The risk of bias
The results of the risk of bias calculations are shown in Table 2 A -random sequence generation B -allocation concealment C -blinding of participants and personnel D -blinding of data analyst E -incomplete outcome data F -selective reporting 
BDNF quantification
As shown in Figure 3 , the five eligible studies included 104 participants in the exercise (intervention) group and 95 participants in the control (no exercise) group. The standard mean difference did not reach significance (Z=0.32, p=0.75); furthermore, the heterogeneity was low (I 2 =0%).
DISCUSSION
The result of this meta-analysis indicates that physical exercise had no effect on BDNF in serum/plasma, at least in so far as the eligible articles are concerned.
Several studies have examined the effect of physical activity on BDNF in various disease states. Dinoff et al.
(2016) conducted a meta-analysis of 29 articles (n=1212), and reported that aerobic exercise, but not resistance training, increased the resting concentration of BDNF in healthy people (standard mean difference =0.66). In several mental disorders, systematic reviews and metaanalyses showed a positive effect of physical exercise on BDNF. Jensen et al. (2016) examined whether physical exercise increased BDNF in patients with mild cognitive impairment and dementia in a systematic review, and reported that almost all of the research showed physical exercise to have a positive effect. Sanada et al. (2016) examined the effect in patients with schizophrenia in a meta-analysis of six articles (n=252), and also reported a positive effect on BDNF (standard mean difference =0.95). Finally, Mackay et al. (2017) investigated the effect in patients with neurological disorders with a meta-analysis of five articles (n=142), and reported that aerobic exercise increased BDNF (standard mean difference =0.84). Therefore, it is likely that physical activity increases BDNF in a number of different neuropsychiatric diseases.
However, the data herein on patients with MDD did not confirm the effect; furthermore, heterogeneity was low, lending credence to the data. The reason may be related to the duration of the effects of physical activity on BDNF. In healthy people, Szuhany et al. (2015) conducted a meta-analysis examining differences among the effects of physical activity on BDNF according to three different exercise conditions: A single session of exercise; a session of exercise following a program of regular exercise; and resting BDNF levels following a program of regular exercise. They found that the effect size of resting BDNF levels was small, a finding similar to that observed among patients with MDD. Laske et al. In patients with MDD, a meta-analysis of eight studies by Brondino et al. (2017) noted that the effects of physical activity on global neurocognition were negligible, but those on visual learning were significant. This suggests that in patients with MDD, exercise may have limited effects on neurocognitive functions aside from visual learning. Oertel-Knöchel et al. (2014) compared the patterns of influence of aerobic exercise on neurocognition between patients with schizophrenia and those with MDD, and found a greater effect in schizophrenia than MDD. Finally, considering our meta-analysis' results, BDNF may not be a likely candidate for mediating the mechanism which underlies the limited benefit of physical exercise in patients with MDD. In a pharmacological study, serum BDNF in treatment-resistant MDD was unaffected by antidepressant treatment, whereas serum BDNF in treatment-respondent MDD was significantly different (Yoshimura et al. 2007 ). All participants in this metaanalysis had severe symptoms of MDD, and three of the five studies analyzed inpatients. Thus, the participants in some or all of these studies might have antidepressant-resistant MDD, which could alter the results herein. Future studies are needed to assess the effect of physical exercise in patients with MDD who responded to antidepressant therapy. This meta-analysis has several limitations. First, risk of bias was difficult to assess. Only two categories clearly showed low risk of bias (less than half of the categories). Interventions such as physical exercise tend to be recognized as interventions by many healthcare workers, suggesting a moderate risk of bias in selective reporting and blinding of personnel. Second, only one author reviewed and assessed the articles and risk of bias. Considering that Cochran recommends two authors at least, a future review with multiple assessors is needed. Third, the number of eligible articles was relatively small, with only five articles and 199 participants included. Therefore, there are the risk of false-zero heterogeneity, our results may differ when more studies can be included.
CONCLUSION
This review and meta-analysis aimed to examine whether physical exercise increases BDNF in people with MDD. Five studies were eligible and their features were as follows: subjects had severe symptoms of MDD; subjects in 4 of the 5 eligible studies were inpatients; interventions lasted more than 40 minutes per session; the drop-out rates were low; and risk of bias was moderate. However, the effect of physical exercise on BDNF did not reach statistical significance. The mechanism of the effect of physical exercise on depressive symptoms of MDD was not related to BDNF.
